Ainos, Inc. AIMD
Regular-session close
After hours · Nov 20, 7:44 PM ET
- YTD
- -28.05%
- 1 year
- -38.22%
5D +0.20 (+21.46%)
- Market cap
- 8.93M
- Revenue (ttm)
- 40.63K
- EPS (ttm)
- -2.14
- Shares out
- 14.54M
- YTD return
- -28.05%
- 1-year return
- -38.22%
- 50-day average
- 0.4748
- Volume
- 230.75K
- Avg volume
- 1.87M
- Open
- 1.10
- Previous close
- 1.11
- Day's range
- 1.10 – 1.28
- 52-week range
- 0.469 – 3.16
- Beta
- 1.41
Key statistics
- 200-day average
- 0.74847
- Enterprise value
- 13.36M
- Price / sales
- 167.25
- Price / book
- 0.36
- Free cash flow
- 621.86K
- Total cash
- 5.16M
- Total debt
- 12.27M
- Return on equity
- -70.60%
- Short % of float
- 1.44%
Fundamental scorecard
6 of 25 checks passed on AIMD’s reported financials
6of 25 checks passed
- Value 1 of 5
- Growth 3 of 5
- Profitability 1 of 5
- Financial health 1 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | 0.00 | -0.33 | — | — |
| Aug 5, 2024 | Jun 1, 2024 | 0.00 | -0.49 | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | -0.57 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | -0.75 | — | — |
| Aug 11, 2023 | Jun 1, 2023 | 0.00 | -0.60 | — | — |
| May 12, 2023 | Mar 1, 2023 | 0.00 | -0.65 | — | — |
About Ainos, Inc.
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- ainos.com
News
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session Ainos Q3 EPS $(0.25) Up From $(0.64) YoY
Reported Earlier: Ainos Q3 Sales $642.889K Up From $2.167K YoY
12 Information Technology Stocks Moving In Monday's Pre-Market Session
12 Information Technology Stocks Moving In Friday's After-Market Session
12 Information Technology Stocks Moving In Thursday's After-Market Session
12 Information Technology Stocks Moving In Thursday's Intraday Session
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
12 Information Technology Stocks Moving In Monday's After-Market Session
12 Information Technology Stocks Moving In Wednesday's After-Market Session
Your note
Sign in to keep a note on AIMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHANG WEN-HAN | Director | Conversion of Exercise of derivative security | Jan 30, 2024 | 106,265 |
| CHIANG YAO-CHUNG | Director | Conversion of Exercise of derivative security | Jan 30, 2024 | 54,932 |
| LEE HSIN LIANG CHRISTOPHER | Chief Financial Officer | Conversion of Exercise of derivative security | Nov 25, 2024 | 22,376 |
| LEE TING CHUAN | Director | Conversion of Exercise of derivative security | Nov 25, 2024 | 327,432 |
| LIN LAWRENCE K | Officer | Conversion of Exercise of derivative security | Feb 15, 2024 | 11,260 |
| SUNG MENG-LIN | Chief Financial Officer | Conversion of Exercise of derivative security | Feb 15, 2024 | 61,050 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| UBS Group AG | 0.48% | 67,007 | 31.31K | Sep 29, 2024 |
| Virtu Financial LLC | 0.33% | 45,221 | 21.13K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.17% | 23,321 | 10.90K | Sep 29, 2024 |
| Citadel Advisors Llc | 0.17% | 24,058 | 11.24K | Sep 29, 2024 |
| Blackrock Inc. | 0.11% | 15,325 | 7.16K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.06% | 8,763 | 4.09K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.14% | 19,951 | 9.32K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.02% | 3,305 | 1.54K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.01% | 1,966 | 918 | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.01% | 1,980 | 925 | Oct 30, 2024 |
